When you hear about compounded semaglutide, it means a compounded medication that may use semaglutide as an ingredient
The mechanisms of action that can explain the respective effects on different conditions in the human body are discussed as well

In the United States, FDA guidelines indicate these medications for: Adults with a BMI of 30 or higher (obesity) Adults with a BMI of 27 or higher who also have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea You should discuss GLP-1 medications with a physician if you have any of the following, as they may affect which medication is appropriate or require additional monitoring: Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) a contraindication for all GLP-1 drugs History of pancreatitis Kidney disease or a history of gallstones Pregnancy or plans to become pregnant History of eating disorders The Critical Factor Most People Overlook: Muscle Loss Here is something that rarely appears in GLP-1 marketing: these medications can cause significant muscle loss alongside fat loss, particularly at the aggressive weight loss rates they enable

As such, the effect of GLP-1RAs on DR should be viewed with caution
These side effects usually get better after a few weeks as your body adjusts to the medication
Signs your medication may not be working If you have been on tirzepatide for four or more weeks with absolutely no appetite reduction, no weight change, and no GI effects, something may be wrong